Leaflet thickening and motion after transcatheter aortic valve replacement: Design and rationale of the Rotterdam edoxaban trial.
暂无分享,去创建一个
P. D. de Jaegere | N. Van Mieghem | R. Budde | J. Daemen | M. D. de Ronde-Tillmans | J. Ooms | T. Hokken | M. V. Van Wiechen | R. Adrichem | A. Hirsch | W. Knol | Ikram el Azzouzi | M. V. van Wiechen